ABVC BIOPHARMA, INC.
New Filing
CIK: 0001173313·Biotechnology·NEVADA·Filed: Mar 2, 2023
Total Offering
$3,704,167
Amount Sold
$3,175,000
Investors
1
First Sale
Feb 23, 2023
Offering Details
- Type
- Debt, Option to Acquire, Other: Convertible Note
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Howard Doong | Related Person |
| Eugene Jiang | Related Person |
| Chang-Jen Jiang | Related Person |
| Che-Wei Hsu | Related Person |
| Francis Chen | Related Person |
| Hsin-Hui Miao | Related Person |
| Norimi Sakamoto | Related Person |
| Shuling Jiang | Related Person |
| Tsang-Shann Jiang | Related Person |
| Tsang Ming Jiang | Related Person |
| Yen-Hsin Chou | Related Person |
| Yoshinobu Odaira | Related Person |
| Leeds Chow | Related Person |
Company
SEC Filing
0001213900-23-016641
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free